Inhibitors of Membrane Type-1 Matrix Metalloproteinase for the Treatment of Insulin-Dependent Diabetes Mellitus

Inhibitors of Membrane Type-1 Matrix Metalloproteinase for the Treatment of Insulin-Dependent Diabetes Mellitus

Inventor(s): Strongin

Type of Offer: Licensing